More than half of patients on a statin who experienced an adverse event stopped taking the drug, but more than 50% also restarted the drug or tried a new statin later on, according to researchers at Brigham and Women's Hospital in Boston. The study in the Annals of Internal Medicine showed 66% of patients who stopped taking a statin for reasons besides an adverse event had another statin prescription over the following year, and 98% of those who restarted statin therapy were still compliant a year later.

Related Summaries